Aetna Inc. (AET) Falls 2.98% for January 15

Equities Staff |

One of the S&P 500’s big losers for Friday January 15 was Aetna Inc. (AET). The company’s stock fell 2.98% to $105.02 on volume of 3.51 million shares.

The stock opened the day at 106.08 and traded between a low of $103.12 and a high of $108.24. The stock finished the day down $3.23 per share. Aetna Inc. has an average daily volume of 3.34 million and a total float of 348.7 million shares. The 50-day SMA for Aetna Inc. is $106.60 and its 200-day SMA is $111.87. The high for the stock over the last 52 weeks is $134.40 and the low is $90.00.

Aetna Inc. is a health care benefit company, which offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.

Aetna Inc. is centered in Hartford, CT, and has 48,800 employees. Today’s trading day leaves the company with a market cap of $36.62 billion. The company has a P/S ratio of n/a, P/B ratio of 2.31, and a 17.3.

For a complete fundamental analysis analysis of Aetna Inc., check out Equities.com’s Stock Valuation Analysis report for AET. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

OncoSec Medical Incorporated

OncoSec Medical Inc is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the…

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…